Main Topic: The ongoing fight against COVID-19 and what can be done better as a country in the next pandemic.
Key Participants:
Key Points:
Takeaways:
Theme music fades out
Sean Rameswaram
Support for Today Explained comes from Adio. Adio is an AI-native customer relationship management platform that Adio says is built for the next era of companies. A powerful data structure adapts to your business model, syncs in all your contacts in minutes, and enriches your business with actionable data. Adio says it also allows you to create those email sequences, those real-time reports, those powerful automations, which they claim can help you build what matters most, your company. You can go to adio.com slash todayexplained to get 15% off your first year. That's A-T-T-I-O dot com slash todayexplained.
Not all journalism is the same. Take The Guardian. Our coverage has something unique, fierce independence. Nobody owns us or tells us what we can and can't say. So we're free to report the whole picture. We connect what's happening in Washington to the rest of the globe, expose corruption wherever we find it, and give fresh perspective on everything from wellness and soccer to culture, the climate and more. Read, watch and listen to The Guardian for free at theguardian.com.
It's Today Explained. I'm Halima Shah sitting in Sean Rameswaram's chair in Washington, D.C. because Sean is in California. and you're about to hear the conversation he had with two people who've been tasked with managing the government's response to COVID-19. Sean's conversation was recorded yesterday in Los Angeles at this year's Code Conference, where the biggest names in business talk about tech, and in this year's case, the pandemic. The conversation has been lightly edited for clarity and time.
Hello, everyone. Remember when this thing was still called the novel coronavirus? Way back then, in late February 2020, a federal official said, ultimately, we expect we will see community spread in the United States. It's not a question of if this will happen, but when this will happen, and how many people in this country will have severe illnesses. This official said she had told her family that morning, we need to be preparing for significant disruption of our lives. She said businesses might want to consider remote work options. She warned that American public schools might have to close. She said parents should look at child care options. Again, late February 2020, right? It was the first time such a stark warning had been issued by the federal government. The stock market didn't like it. The president at the time didn't like it. Senator John Kennedy of Louisiana said dire warnings like these were, quote, bullshit. But they weren't. A year and a half later, we're still stumbling through this thing, even with vaccines. So today at Code, we're going to talk about the ongoing fight against COVID-19 and what we can do better as a country the next time around, the next pandemic.
Joining me to talk through it all is that fortune teller from the federal government back in February 2020. Her name is Nancy Messonnier. She was the director of the National Center for Immunization and Respiratory Disease at the CDC at the time. Now she's the executive director for pandemic prevention and health systems at the Skoll Foundation. Also, Andy Slavitt, he was the guy the Obama administration brought in to save healthcare.gov from becoming a cautionary tale, and he served as a senior advisor to the Biden White House on COVID response. Please welcome Dr. Nancy Messonnier and Andy Slavitt.
Pick a chair. Thanks for joining us, guys.
So let me start by asking each of you, we're sitting on stage at a conference, which feels like progress, but in January of this year with the vaccine starting to roll out in earnest where do you honestly think we'd be in September in the fall of 2021? What year is it? 2021.
Andy Slavitt
You know there's always this you gotta hope for the best and expect the worst kind of feeling. I've worked on vaccines for 25 years and frankly in the midst of working on that vaccine knowing how good the data was on the vaccine. I thought the public would rush to get it, that the data on safety and effectiveness and the recommendations from all the scientific experts would have people queuing up. By this point, I thought we'd have widespread, high vaccination coverage, and we'd be back to living our normal lives.
Look, January, where we sat, this is hard to remember this, you know, only about 40% of Americans said they'd be vaccinated. We had little to no vaccine inventory in the country nobody could get an appointment alpha was roaring through, which was before delta and about 5,000 people a day were dying at peak. And so I think we both saw tremendous progress, and then I think we hit the wall that that Nancy described where you know 40 became 70 but it turned out that that last 30 made a really big difference and for all the people that in this country that for whatever reason don't believe in science are suspicious of authority, etc. etc. you know you can win most things 70-30. Turns out you can't win a pandemic 70-30.
Sean Rameswaram
The latest convoluted chapter of this saga has been booster shots. So I'm just going to run through a timeline here, a rough timeline, and correct me if I get anything wrong. Biden says in August that he wants the vaccinated general public to get boosters starting on September 20th. Immediately, you're hearing these rumblings that health officials think the administration is jumping the gun. The head of the WHO says you're giving life jackets to people who already have them while others are drowning. A couple scientists at the FDA say they don't believe there's evidence the general public needs boosters.
They announced their resignations. The FDA's party line says those scientists don't represent the views of the agency. Then last week there's a ton of action. FDA eventually says just give these Pfizer boosters to people 65 and up and those who are at severe risk of illness including potentially essential workers. Then last week the CDC's advisory committee says yes to 65 plus and sure people with severe risk but they exclude essential workers. In what I'm told is a highly unusual move, the director of the CDC, Dr. Rochelle Walensky, goes against her own advisory committee and kind of brings this back to where the president wanted it to be.
People over 65, people at risk, and then essentially anyone who wants to make the argument, they need it, right? Bit of a roller coaster.
Do you two... That was impressive. Thank you, thank you, thank you. Did the Biden administration jump the gun? Did they come out too early with this announcement about September 20th?
Andy Slavitt
It's a messy system. But it's actually the system I want. I want a system where we can see the dissent, where we can see people of differing opinions, where we have, let's face it, very uncertain information about a decision like this, which, as you said, has moral complexity, it has scientific complexity, we have limited amount of information. And sure, would it be great to see everybody uniformly come out and say, this is what we should do? Sure, but in a democracy like this, where we can have people dissenting, we can have people writing opinion pieces, we can have people protesting, and that's okay.
You can do that. We're used to disagreement being violent, but scientific disagreement done the right way is okay, even if it's a little bit confusing. But to parse things a little bit, just a couple of the pieces you said. One is, on the global side, if we absolutely needed these vaccines across the globe, I think we would all agree that a first vaccine in someone's arm is more important than a third vaccine in someone's arm. But the truth is we producing a billion vaccines a month now. Most of the world is well ahead of the U.S. The biggest problem we have globally now is a last mile problem in Africa which is about 6% vaccinated. But we're producing more than enough vaccines. What we have to do is get them from airports into people's arms. The couple hundred million to 150 million that would go into boosters in the U.S., fortunately, wouldn't make a difference.
So we don't have a zero-sum game anymore. And look, for people in the U.S., I think it's particularly clear that if you're over 65 or you're repressed immune system or you're at risk, that a booster will be helpful to you. And it's less clear as you get younger and as you get healthier. And so, you know, I think the argument reflected the difficulty of that judgment.
Sean Rameswaram
Yeah, maybe just to parse the two issues. Around the booster dose, I think the public is used to hearing scientists talk about settled science. And a lot of the disagreement that is scientific occurs behind the scenes. And what you're seeing now is that disagreement about where the science is play out in real time and us making decisions before all the science is settled. And I think that may be the new era going forward.
Nancy Messonnier
On this specific issue, CDC's advisory committee has to look at the data and interpret the data, but then use the data to make a recommendation. And there is inherently in that step of analyzing the data and making a recommendation of subjectivity to it. They have to take the data and parse it through their own values and judgments and experience. If it was purely a technical argument, frankly, you wouldn't need people. You could run it through a computer algorithm and have a result. And so the reason there is an advisory committee with experts is to try to balance out the difference between where the science says where you have to make a judgment.
I think in the story that you told, the one piece that you're missing, which I think is really important, is that the ACIP, the CDC's advisory committee, wasn't unanimous. It was actually a 9-6 vote. And what that means is nine people voted for the recommendation, but six people voted for language that basically is very similar to what Dr. Walensky eventually recommended. And that split you're seeing, I think, showcases the fact that the science wasn't settled and that there was a lot of judgment inherent about it.
Sean Rameswaram
Yeah, and just to finish that point, have you ever been on an advisory committee before?
Andy Slavitt
Absolutely not. If anybody's been on an advisory committee before, you don't get paid to make decisions. You're not accountable if the decision goes right or wrong. So advisory committees are meant to advise. You're meant to get good, smart people to give their opinions. But at the end of the day, Dr. Walensky is the one that has to live with the decision that got made. And so she did a smart thing in saying, I'm going to consider all of your opinions, which were mixed, and what I heard from the FDA, and I'm going to make the call. And she's the one that's got to live with it. She made the right decision. But going against, quote, unquote, an advisory committee, I think is something that is not something we should be frowned about. It's something that we should look at. And as long as people explain their decisions, we should feel very good about.
Sean Rameswaram
That seems well and good. But I guess I still want to know, could the Biden administration have handled it better? Could they have not come out and said, we're hoping to do this thing by September 20th and then have to take that back? Could they have been a little clearer in the rollout of boosters?
Andy Slavitt
Well, look, I mean, having been one of the people in charge of communication in the Biden administration when I was there, I can tell you that every single thing you say needs to be thought through. It needs, you need to understand how people are going to interpret it. And you need to understand that that is absolutely going to happen. So when President Biden said, you know, I want to get this out the week of the 20th, and then he came back and said, subject, of course, to FDA approval, I'm sure he would have liked, in his mind, he would have liked to emphasize that more the first time he said it and said, look, this is the FDA decision. Or maybe not thrown out the date of September 20th.
Well, I think what he was doing with the date of September 20th was he was basically, he had to get the government's engines in motion. He had to get the pharmaceutical chains to be ready to administer shots. So he had to do that, and he had to get the country ready. He had to get boosters in place. There's no way to do that in Washington without that being known. But yes, if you would have emphasized subject to the FDA, would it have been slightly better? Probably.
Sean Rameswaram
I guess I would also say that there is a level of scrutiny of science that is just exponentially more than, again, I've ever experienced before in other public health emergencies. And I think sometimes our scientists or even our public health leaders don't understand how much the public and the media are scrutinizing every sentence and how people are, frankly, talking heads all over the country are picking out words and perhaps taking them out of context of what it was meant.
I think it's a new era that we're living in, and I don't know that our scientists have completely caught up with it. I mean, these resignations don't feel reassuring at the FDA. I feel like it can give the impression that people are afraid that, you know, science may be following politics instead of politics following science.
Nancy Messonnier
Yeah, I think, you know, I spent 25 years at the CDC and I'm really proud of the time I spent there. Proud of what I accomplished and frankly proud to work with a team of incredibly talented and committed scientists. 18 months throwing yourself at a pandemic is a long time and it's not surprising I think that I and many of my colleagues at CDC and FDA and frankly at health departments and at hospitals throughout the country are exhausted and like everybody else I think you think about where you are in your life and what you want to do next.
I had the opportunity to work for Skoll Foundation. It's a tremendous foundation, and it's really a complement to what I've done at CDC. Skoll really focuses on championing the doers, the folks that are at the ground level, at the end of the equation, who are really doing the work, understanding globally that they're the ones that we actually need to champion in order to change the world.
Sean Rameswaram
Are we hearing enough from scientists in this pandemic? Or are we hearing too much from politicians?
Andy Slavitt
You know, it's interesting. This sort of pundit class that Nancy's talking about is sort of emerges in a way that at times can be healthy and at times can be quite unhealthy. I think, as we know, from not just healthcare, but from everything, there's this trap of, you've gotta continue to be edgy and interesting in order to get invited back. And there's not enough people that can make their bones by showing how reasonable they can be and by showing how thoughtful and cogent they can be. And that doesn't get rewarded enough.
So look, I think, thankfully, we live in a society where anybody can speak their minds. These two colleagues at FDA disagreed with an opinion, felt strongly about it, published. They're allowed to publish. Nobody said, hey, don't publish that. Now, it turns out they didn't have all the data that their bosses had. And even then, I think you're gonna make the argument that bosses should have said, hey, wait a minute, look at the complete set of data before you publish. But no one suppressed it. It's out there. And I think that's good.
I mean, I am encouraged by that because if we are going to win back, the mission of this country now needs to be we need to win back the 30% of people who just don't believe in science whatsoever. And they believe scientists are arrogant. They believe scientists never admit they're wrong. They believe that expertise has got them in trouble. And so, you know, there's no way through that except an honest path. Tell the public the truth. Have public debate when it's uncertain, when there are no clear answers, it's going to be messy. We have to accept that messiness.
If we try to package it up and make it neat, it never works out. It never works out. Trying to oversell something to the public and overly package it doesn't work in this day and age. So that means there's going to be a degree of messiness. That messiness requires leadership. And I think it the job of political leaders to say here a lot of noise but here the direction we heading I going to listen to scientists but then we got to head this direction because these are our objectives.
Nancy Messonnier
I think it's a mistake to think that you can completely insulate science from politics, especially of public health. Public health inherently requires the buy-in of politicians to make public policy. And I think we have to accept that and accept that the science is one part of the equation, but it's not the only part of the equation. Public health needs to understand that politicians are thinking around a broader array of issues.
But I also think you touched on something else important, which is epidemiology, which is the science behind public health, in some ways seems pretty simple. And if you look now, it's not just these pundits or scientists that are analyzing the data. The data is very publicly available. And frankly, some of the most interesting analysis is coming outside of the traditional scientific routes. I think we as a country and as scientists have to embrace that. But we also really need to figure out how to teach the public to exist in a world where information is so easily available and how to find their way through it.
Sean Rameswaram
One way is certainly to try to curate that data so that the most reliable data comes to the top. But you can find any opinion that you want online. And if you are a disbeliever, you can find other people that believe the same way that you do. I don't think you can turn off that spigot. I think that's the area that we're in now. And the question is, inherently at our roots, how are we going to move forward as a country? How are we going to teach people to be better consumers of scientific data? And it's not just about health data or even about masks and vaccine. It's more broadly about all the data that's available.
Since you are a scientist, do you think we ultimately ended up in the right place on boosters?
Nancy Messonnier
I think we ended up in a reasonable place, given where the data is. But I am worried about the global picture. You know, you said something earlier, Andy, about nobody could have predicted Delta. While I specifically perhaps agree with you, I would say that what scientists know is that viruses evolve. And we knew that this virus was going to evolve. And we knew that there was the potential for some of those escaped mutants to be more virulent, more transmissible, and frankly, in a more frightening way, more resistant to the vaccines that we have available.
The longer that we let the rest of the globe exist without enough vaccine and the infrastructure to implement vaccination, the higher the risk is that there's going to be another strain of the virus that evolves that escapes the vaccine. And that will then put us right back in the dangerous situation that we've been at. So I think boosters are part of the problem, but you really do need to think about the global picture. And the global picture is vaccines for everyone. That's the number one issue right now.
Sean Rameswaram
After the break, Sean asks Andy Slavitt and Nancy Messonnier how we can do better in the next pandemic. We'll be right back.
Theme music fades in
features such as free overdraft coverage, getting paid up to two days early with direct deposit, so much more. Chime says with qualifying direct deposits, you can be eligible for free overdraft up to $200 on debit card purchases and cash withdrawals. Plus, they say you don't need to worry about monthly fees or maintenance fees. You can work on your financial goals through Chime today. You can open an account in two minutes at chime.com slash explained. That's chime.com slash explained.
Chime feels like progress. Chime is a financial technology company, Not a bank. Banking services and debit card provided by the Bancorp Bank N.A. or Stride Bank N.A. Members FDIC. Spot me eligibility requirements and overdraft limits apply. Timing depends on submission of payment file. Fees apply at out-of-network ATMs. Bank ranking and number of ATMs according to U.S. News and World Report 2023. Chime. Checking account required.
Every day, millions of customers engage with AI agents like me. We resolve queries fast. We work 24-7 and we're helpful, knowledgeable, and empathetic. We're built to be the voice of the brands we serve. Sierra is the platform for building better, more human customer experiences with AI. No hold music, no generic answers, no frustration. Visit sierra.ai to learn more.
Let's talk about the next pandemic a little bit. 700,000 dead were approaching that number. Quickly, being that this is the country we live in, what could have been done better? What could have been done or what should be done next time? Both, I suppose, to avoid that number.
Nancy Messonnier
Let me give you some reasons for optimism for next time. The countries that performed well relative to almost every measure, the economy stayed reasonably steady. They had the fewest deaths per capita. Their health care systems were less constrained. And they were able to continue to provide health care services, had a couple of things in common. One of them doesn't describe us very well. One of them actually might in the future.
The first is actually has nothing to do with your wealth. It has nothing to do with your geography, your closeness to China, whether you're an island nation, none of that. It has to do with the difference between the top decile and the bottom decile income level in your country. The more commonality, the more society understands one another, the more people were willing to take steps for the common good. That doesn't describe the U.S. We look a lot more like Brazil. We look a lot more like Russia. We look a lot more like India than we do like East Asia or Central Europe or Northern Europe.
But the other feature turns out to be even more important. And that is prior experience with pandemics. And look at Hong Kong, you look at Taiwan, you look at Vietnam, you look at countries that all of which are very proximate to Wuhan, very proximate to China. They have reflexive behaviors, putting on masks. Even without government intervention, there were no requirements in Hong Kong that people put on masks, but people had experience with obviously with SARS.
Sean Rameswaram
Yeah, it's interesting. I get where you're coming from. You know, my concern is that we have a short memory and that I've, in my role at CDC... Let me be positive. I will get to a positive part, I promise. But, you know, we have a short memory. We live through a crisis, and then we, I think, intentionally in some ways put that crisis down and move on with our lives, try to focus on the positives. And the energy to fix the inherent problems that cause that crisis don't drive sort of long-term investment.
Now none of those crises I talking about Ebola SARS MERS H1N1 influenza anthrax have been of the magnitude of scope of this. And so I hoping that we as a country will seize the moment and say you know, we're committed to saying never again. And never again means investment to ensure that we have the infrastructure and the people in place for public health in the United States, but also globally.
I think in addition to what you're talking about that didn't work well in the U.S., globally, the kind of global coordination that you need in order to ensure vaccine development and production everywhere across the globe, to ensure that countries have common intelligence, have common approaches, I think that really fell apart too. And, you know, the summit last week, the UN General Assembly Summit, I'm sorry, the UN General Assembly and President Biden Summit was meant to be a launching pad for a new global initiative that really brings in not just the US and governments, but philanthropy and businesses for sort of a whole of society moment to say, we need to seize the moment, we need to use this energy not only to end the current pandemic, but to ensure that we build back better, that is build the kind of infrastructure and systems that will be more resilient for the next time.
Not to bring this back to a dark place, but let's talk about political polarization for a minute here, especially as it relates to this pandemic. I mean, 700,000 dead, President Biden likes to come out and remind us of this unimaginable amount of death, and it feels like half the country's hearing it and half the country doesn't care. Half the country still wants to fight about masks on planes and make, you know, flight attendants' lives a nightmare.
Have we learned anything about how to combat political polarization in a public health crisis over the course of two administrations?
Andy Slavitt
Yeah, I can't tell you, begin to tell you how sad it makes me. And I have talked to a few friends who are not mask wearers and aren't vaccinated. And, you know, I go back to those conversations where even knowing me and trusting me, I can't convince them that those are the right things to do. I think we have to really move forward in a way that respects our differences and understands that people inherently believe differently.
To me, it's about scientific literacy. People trust those that they're closest to in their own communities who they trusted before the crisis happened. And I think we really need to understand where this is coming from. It's coming from deep distrust of our institutions and our scientists. And what it means if it's been that long to develop, you're not going to solve it quickly. And you're certainly not going to do well trying to solve it in the midst of the crisis.
So I think what it points to is the need to really invest in the development of those long-term relationships of public health officials in those communities who can be trusted, but are also really rooted in the science, and also healthcare providers in those communities that have access to the right information and really build long-term relationships with their communities and their patients.
Sean Rameswaram
And this is a tech conference, so I'm contractually obliged to ask if tech can help. I mean, a lot of the disinformation is spreading on tech. Okay, I'm going to let you start this. Can you combat disinformation with tech? Are we? Are we doing a good enough job?
Andy Slavitt
Yeah, Facebook could do better. They know they could do better. I think others of the social media companies, I think, recognize the challenge and I think work at it. I think, unfortunately, of the people who aren't vaccinated, I think the data is two-thirds of them believe one of five major falsehoods about the vaccine. And most of them say they get their information from social media. And Facebook and WhatsApp are real problems. And that's just the reality.
And is it addressable by them? Yes, I believe it is. And that's a long conversation. You can read the New York Times piece that showed the fight I was having with Facebook from the White House if you want. I also think, though, there's also a part of this that is not the media, but sort of more people-focused. You know, when I was a kid, if we had to do a research paper, we went to the library. And now I'm dating myself. And my teacher told me that the encyclopedia was not an appropriate reference. Reference. I had to actually look at real reference texts.
I think we need to do a better job of teaching people that Googling something or looking it up in social media is not research. Research is knowing the source of the data, knowing who you trust, and being able to sort of sort through all the misinformation to find the kernel of truth. And I think by the same token, scientists need to do a better job making reliable information available and accessible and reliable by people. Interpretable.
Sean Rameswaram
We're living currently in this little bubble in the optimal version of this pandemic and a lot of people aren't and haven't been for over a year and a half now. Have we gotten any better at dealing with that or learned some lessons that can help us in the next pandemic?
Andy Slavitt
Look, I mean, we opened our first federal facility right here in East Los Angeles, and it was mobbed on the first day by people from Beverly Hills. Probably the first time they've been in East Los Angeles in a long, long time, I would venture to say. And when we looked at the peak of deaths here in January, the Western part, you know, Santa Monica, Berlioz, was some of the safest parts of the country. And East L.A. was where all of the deaths were occurring.
And, you know, I personally think that's the whole thing right there. That's the whole thing right there. Out of sight, out of mind, I can't say how many people have said to me, Andy, I don't know a single person that died of COVID. This was the last year, so maybe that's changed. And, you know, my response was always, you do know people dying of COVID. And they're like, no, I don't. And I'm like, well, the person who grows your food, the person who drives the truck to bring the food to the warehouse, the people in the warehouse, the people in the grocery store, you may not know their names, but those are all the people that are dying.
Sean Rameswaram
That was Sean Ramos-Furram talking to Andy Slavitt who used to work in the Biden White House and Nancy Messonnier who is a director at the CDC. Thanks to Vox Media's Michelle Berg and Andy Tao for their help with the live show and thanks to Vox's Dylan Scott for help with the questions. I'm Halima Shah. It's Today Explained. Alright, you it's Bill Holzer.